A new method is described in which the Salkowski reaction is used for the rapid selection of alkaloid-producing mutants of the ergot fungus. This method was used to investigate the influence of a second mutation with N-methyl-N'-nitro-Nnitrosoguanidine (NTG) on various mutants selected by a preliminary NTG mutation of Claviceps sp. strain SD 58. Three groups of mutants were used: high alkaloid producers, low alkaloid producers, and auxotrophs. Results indicated that a second mutation of all three types of mutants could improve alkaloid yield and vegetative vigor. In addition, a second mutation increased the frequency of auxotroph production. The difficulty of producing stable mutants from ergot strains that have multinucleated cells and that do not readily produce conidia in culture, such as an ergotamine-producing strain, was overcome by first forming protoplasts of the fungus and then subjecting them to the mutagen. Stable auxotrophs were obtained in this manner.
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Mutagenesis followed by subsequent selection of a strain producing superior yields is an important technique in increasing the fermentative yield of antibiotics. For example, penicillin yields have been increased by several hundredfold since the 1940s, when penicillin was first produced commercially (14) . On the other hand, the application of this process to increasing the fermentative yield of ergot alkaloids has been rather limited. One of the first reports by Kobel et al. describing a mutant strain of Claviceps purpurea which produces an increased amount of alkaloids was published in 1962 (8) , and subsequently, these workers have obtained an ergocristine-producing C. purpurea strain which shows a 180-fold increase in alkaloid production over the parent strain after an eight-step mutation-selection with different mutagens (9, 10) . Their selection technique involves the isolation of 1,000 colonies after each mutation and the subsequent testing of each isolate in shake culture for alkaloid production. It is thus a timeconsuming process.
We report here what we think is an improved and more rapid method for selecting mutants of the ergot fungus with increased alkaloid production abilities and techniques for obtaining auxotrophic mutants of two strains of the fungus, including a multinucleated, heterocaryotic strain.
MATERIALS AND METHODS
Culture procedures. The ergot strains used for this study were Claviceps sp. strain SD 58 (ATCC 26019), originally isolated from a sclerotium obtained from Pennisetum typhoideum Richard, and Claviceps purpurea (Fries) Tulasne (ATCC 20102), an ergotamineproducing strain isolated from a sclerotium formed on rye (Secale cereale L.).
Claviceps sp. strain SD 58 was maintained on Czapek-Dox or NL-406 agar slants (15) and grown in shake culture at 24°C and 220 rpm on a rotary shaker. Cultivation of the strain was achieved by inoculation of 500-ml Erlenmeyer flasks containing 100-ml portions of culture medium NL-406 with portions of the mycelium from an agar slant. After 10 days, the cultures were homogenized in a Waring blender at high speed for 1 min, and 2-ml portions of the cultures were transferred to fresh NL-406 medium. This step was repeated until the cultures were homogeneous in appearance. However, after the sixth transfer, the alkaloid titer gradually decreased. The culture procedure, starting from growth on slants, was repeated as necessary.
C. purpurea was maintained on agar slants containing T2 medium (3) and grown in shake culture at 24°C and 220 rpm for 3 weeks on a rotary shaker. Cultivation was achieved by homogenizing the mycelium grown on slants with 10 ml of T2 liquid medium. The homogenized mycelium was transferred to flasks containing 100-ml portions of T2 liquid medium. After 8 to 10 days, 10-ml portions of these seed cultures (precultures) were transferred to production medium NL-833 (13 Protoplasts were formed from the mycelium of the C. purpurea strain, which is thought to be a heterocaryote (17) , and these were subjected to the same mutation procedures used for strain SD 58.
Protoplast formation. Protoplasts were prepared by a modification of the method of Keller et al. (7) . The C. purpurea mycelium from 8-day-old production medium (NL-833) was harvested on a funnel of coarse sintered glass and washed three times with a small volume of 0.4 M sucrose solution. We suspended 2.5 g of mycelium in 30 ml of protoplast medium consisting of 0.8 M sucrose, 10 mM sodium citrate (pH 4.7), 10 mM MgCI2, and 10 mM CaC12. After careful homogenization, 1.2 ml of ,-glucuronidase type H-3 crude solution from Helix pomatia (Sigma Chemical Co., St. Louis, Mo.) was added, and the mixture was incubated with shaking (120 rpm) at 26°C for 12 h, at which time protoplasts were observed under a microscope.
The protoplast solution was diluted threefold with protoplast medium and filtered through glass wool to remove large mycelial fragments. The filtered solution was centrifuged at 5,000 x g for 20 min, and the top layer of protoplasts was collected in a test tube. The supernatant was discarded, and the protoplast residue was resuspended in 20% of the original volume of protoplast medium. This procedure was repeated, and the combined layers of floating protoplasts were collected and resuspended in 10 ml of protoplast medium, 9 ml of which was added to 1 ml of the NTG solution. After mutagenesis, the protoplasts were plated on NL-406 agar with the pin device. The regeneration of intact cells took place within 5 days.
Selection technique. Two types of selection criteria were employed: the amount of alkaloid produced by the mutant and nutritional deficiency.
Selection based on alkaloid production was accomplished by utilizing the Salkowski reaction (11) . In this method, the mutant colony is replicated before the experiment, and the reverse side of the original colony is then scraped until no traces of agar are present. After the reverse side is sprayed with a reagent consisting of 1 ml of 1.5 M FeCl3 solution and 100 ml of 60%o sulfuric acid, the colony is incubated at 60°C for 5 min. The intensity of the blue color which develops corresponds to the amount of alkaloid present.
To select auxotrophic mutants, colonies were replicated on plates with unsupplemented NL-406 medium without yeast extract. If the mutant failed to grow on this minimal medium, the original mutant colony was transferred into 30 ml of liquid NL-406 medium and incubated at 24°C and 220 rpm for 5 to 7 days or until mycelial growth was sufficient for subsequent transfer to fresh medium. The culture was filtered under aseptic conditions, and the mycelium was washed with sterile distilled water several times. The mycelium was then suspended in 30 ml of sterile distilled water. One loopful of suspension was spread on a fresh minimal medium agar plate, which was incubated at 24°C for 14 days. Leaky mutants were discarded or submitted to the selection procedure a second time. Nonleaky mutants were grown in a submerged culture of complete medium and then tested for specific nutritional deficiencies as described by Holliday (6) .
RESULTS AND DISCUSSION
In our laboratory, wild-type strain SD 58 normally produces clavine-type alkaloids in the range of 500 to 800 ,g of total alkaloids per ml of culture filtrate or about 35 to 60 ,ug of total alkaloids per mg of mycelial dry weight. After subjecting the wild-type strain to mutation and examining 11,500 resultant colonies, we selected three groups of mutants, which were designated first-stage mutants.
The Salkowski reaction was used to differentiate two groups of alkaloid production mutants. High-alkaloid-producing mutants became dark blue to black and, upon submerged culturing, produced alkaloid in titers of >1,200 ,ug/ml of culture filtrate. We isolated 28 of these mutants, 3 of which produced alkaloid in titers of >2,000 ,ug/ml of culture filtrate. The 13 low-alkaloidproducing mutants isolated were light blue to APPL. ENVIRON. MICROBIOL. Second-stage M-71 mutants showed an alkaloid production level -1.5 times that of first-stage mutants and s2.8 times that of the wild type strain, as determined on the basis of micrograms of alkaloid per milliliter of culture filtrate (1.1 times that of first-stage mutants and 1.9 times that of the wild type, as determined on the basis of micrograms of alkaloid per mg of dry mycelium). Compared with levels produced by firststage M-71 mutants, those produced by two second-stage mutants were higher in the culture filtrates but lower in the dry mycelia, indicating an increase in growth rate.
Mutants M-26 and M-71 were also tested for auxotrophs. The frequencies of M-26 and M-71 auxotrophs were 1.3 and 2.8%, respectively, whereas the frequency of auxotrophs resulting from mutation of strain SD 58 was approximately 1/1,500 (0.07%). Thus, a second mutation with previously mutated strains produced a higher frequency of auxotrophs in the second-stage mutant population.
Thin-layer chromatography of alkaloid extracts from second-stage mutant cultures showed alkaloid patterns similar to those found for extracts from first-stage M-26 and M-71 mutants as well as strain SD 58. However, the chanoclavine-agroclavine-elymoclavine proportion differed from those of strain SD 58 and the first-stage mutants. No mutants blocked in the ability to synthesize the full complement of clavine-type alkaloids were found.
In studies utilizing low-alkaloid-producing mutants, it was found that the first-stage mutants fell into two groups. The first group was characterized by a rate of growth similar to that of strain SD 58. When these mutants were subjected to a second mutation, some cells survived. A second group grew very slowly, possibly indicating impaired metabolism. This group of mutants did not survive a second mutation.
One mutant of the first group, M-64, had an alkaloid titer of 4.5 pug/mg of dry mycelium (44 ,ug/ml of culture filtrate). The frequency of cell survival was 0.1% after a second mutation. None of the six second-stage mutants isolated were able to produce an increased level of alkaloids, and four were auxotrophs. Another mutant of the first group, A-176, possessed morphology and growth rate similar to those of strain SD 58. The frequency of cell survival was 2.9% after a second mutation, and of the 162 mutants obtained, 11.1% were auxotrophs. None of the second-stage mutants produced alkaloid titers as high as those produced by highproducing strains (1, 200 ,ug/ml of culture filtrate); however, four A-176 mutants produced an alkaloid titer in culture filtrate similar to that produced by strain SD 58. On the other hand, the alkaloid titers in dry mycelium were about one-half that of the wild type (Table 2) , indicat-VOL. 45, 1983 on July 5, 2017 by guest http://aem.asm.org/ Downloaded from ing an increased growth of the mutants that resulted in a greater mycelial mass. Generally, mutant A-176 grew slowly and did not produce much mycelium. An improvement in vegetative development, as indicated by an increase in mycelial growth, may be a distinct advantage, since strains which have vigorous vegetative growth have a better chance for surviving, especially during long-term preservation, and for providing enhanced vegetative development in tank fermentation.
Auxotrophic mutation generally leads to lower productivity of organisms producing secondary metabolites (1, 12) . This was true for auxotrophic SD 58 mutants, even though they were grown in a nutritionally supplemented medium. There was a similarity between the low-alkaloidproducing mutants and the auxotrophic mutants in growth patterns. Several auxotrophs were subjected to a second mutation, and many of them did not survive. The surviving second-stage mutants were classified into two groups: the first group retained the auxotrophic properties: inability to survive in unsupplemented medium and low alkaloid production, and the second group, designated "auxotrophic revertants," were prototrophic, as characterized by the ability to grow in unsupplemented medium and the regaining of alkaloid production levels.
Mutants M 2-29 (Cys-/Met-) and M 10-10 (Lys-) were subjected to a second mutation, and the frequencies of cell survival were 0.6 and 3.6%, respectively. Of 92 mutant M 2-29 colonies isolated, 13% were high alkaloid producers and 48% were auxotrophs. Of 110 mutant M 10-10 colonies, 15% were high alkaloid producers and 45% were auxotrophs. Total alkaloid production of representative high-alkaloid-producing mutants selected from the second mutation is shown in Table 2 .
All auxotrophic strain SD 58 mutants that produced high alkaloid levels after a second mutation reverted to prototrophs. Reversion resulted in an alkaloid production level in the mycelium that was -<1.6 times that of the original prototroph. Mutants which retained their auxotrophic character were poor alkaloid producers.
A possible explanation for the increase in the production of a secondary metabolite by auxotrophic revertants is that the revertants are feedback-resistant mutants in which production of a primary metabolite precursor is no longer regulated, resulting in its increase. If the amount of this precursor is rate limiting in biosynthesis, there would be an increased production of the secondary metabolite. Reversion of a Streptomyces viridifaciens methionine auxotroph has been shown to increase chlortetracycline production threefold (4), and since methionine is a precursor of the antibiotic, perhaps the increase is due to this mechanism. In another case, reversion of cysteine, leucine, and isoleucine auxotrophic Streptomyces lipmanii mutants has been shown to result in an increase in the production of methoxycephalosporin C (5). The same study also showed that the revertants excrete these amino acids into the culture medium, indicating an increase in production. Because the amino acids can be used as precursors of the antibiotic by some of the revertants, there is improved antibiotic production. Similar mechanisms may be operating in our Claviceps system.
The yield improvements of strain SD 58 after a second mutation are shown in Table 3 . We think that our results indicate that a series of stepwise mutations and selections conducted with strain SD 58 would improve both alkaloid yield and vegetative vigor.
C. purpurea, an ergotamine-producing strain, presented special problems in mutation and selection studies. This strain produces few, if any, conidia in culture, and the mycelial cells are multinucleated. Spalla and Marnati (18) have made the general observation that alkaloid-producing strains of C. purpurea are heterocaryotes and do not produce conidia under normal conditions. The difficulty of obtaining mononucleated cells for mutagenic treatment was circumvented by preparing protoplasts of the fungus before treatment with the mutagen. This procedure increased the chances for separating out mononucleated entities when plating with the pin 
